Specialty Drug Distribution market will register a +12.0% CAGR in terms of revenue, the global market size will reach US$ 1270 million by 2025, from US$ 640 million in 2019.
The global average gross margin of specialty drug distribution is on the trend to decrease from 7.85% in 2011 to 5.97% in 2015. Depending on the global economic situation, gross margin will be on a downward trend in the next five years.
Types of special drugs include oncology, rheumatoid arthritis, multiple sclerosis, hemophilia and others. In 2015, the proportion of oncological drugs is about 45.8%, and in 2015, the proportion of rheumatoid arthritis drugs is about 15.4%.
Specialty medicines are widely sold in retail, home health, clinics and pharmacies. Most of the specialty medicines are sold in the clinic, and the market share in 2015 is about 37.6%.
Amerisource ,Mckesson ,Cardinal Health, PHOENIX, Medipal Holdings, Alliance Healthcare, Celesio, Sinopharm, Accredo, Pharma, Anda, Jointown, Max Pharma, Avella
For Sample Copy of this report: https://healthcareintelligencemarkets.com/request_sample.php?id=135683
Product Type Segmentation
Key Target Audience:
Avail Discount on this Report
- Subcomponent Manufacturers
- Industry Association
- Downstream Vendors
Table of Contents:
Global Specialty Drug Distribution Market Research Report
Specialty Drug Distribution Market Overview
Global Economic Impact
Competition by Manufacturers
Production, Revenue (Value) by Region
Supply (Production), Consumption, Export, Import by Regions
Production, Revenue (Value), Price Trend by Type
Analysis by Application
Manufacturing Cost Analysis
Industrial Chain, Sourcing Strategy and Downstream Buyers
Marketing Strategy Analysis, Distributors/Traders
Market Effect Factors Analysis
Get Complete Report
At HealthCare Intelligence Markets
Address: 90, State Office Center,
90, State Street Suite 700,
Albany, NY 12207
Phone: +1 (888) 616-2766